ATOPIC DERMATITIS (AD)

This study tested a new ointment called MH004 for people with mild to moderate eczema (atopic dermatitis). It involved 375 teenagers and adults who applied the ointment or a placebo cream twice daily for 8 weeks, followed by a longer safety period. The main goals were to see if t…

This study monitored Korean patients already prescribed upadacitinib for conditions like rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Researchers tracked side effects and whether patients' symptoms improved over about 28 weeks of standa…

This study tested whether adding N-acetyl cysteine (NAC) to a standard moisturizing cream could help people with mild to moderate eczema. One hundred participants were randomly assigned to use either the NAC cream or the standard cream alone. Researchers measured changes in skin …

This early-stage study tested a new ointment called MH004 for people with mild to moderate atopic dermatitis (eczema). The first part checked the safety of different doses in healthy volunteers. The second part then tested if the ointment could reduce the severity of eczema rashe…

This study tested a cream called roflumilast for people with mild to moderate eczema (atopic dermatitis). 354 participants applied the cream or a placebo cream once daily for four weeks. Researchers measured how well it cleared skin and reduced itching compared to the placebo.

This study tested whether an intravenous medication called EVO301 could help control moderate to severe eczema in adults. 71 participants with significant eczema covering at least 10% of their body received either the drug or a placebo. Researchers measured changes in skin severi…

This study tested whether an experimental drug called LW402 can reduce symptoms of moderate-to-severe eczema (atopic dermatitis). 144 patients with significant eczema coverage received either the drug or a placebo for 12 weeks. Researchers measured how much skin redness, thicknes…

This study tested how well a high-protection sunscreen was tolerated by adults with mild atopic dermatitis (eczema). Over 22 days, researchers checked if the sunscreen irritated the skin or affected its natural protective barrier. The goal was to see if this sunscreen is suitable…

This study tested whether a high-protection sunscreen (SPF50+) is gentle enough for children with eczema (atopic dermatitis) to use daily. Twenty-two children with mild eczema used the sunscreen at home for 22 days. Doctors and parents checked how well the children's skin tolerat…

This study tested a calming cream for people with mild to moderate atopic dermatitis (eczema). Over 56 days, 42 children and adults applied the cream twice daily under a dermatologist's supervision. Researchers measured changes in skin redness, dryness, itching, and overall quali…

This study aimed to understand the safety of using the medication dupilumab during pregnancy. Researchers followed 581 pregnant women in North America, comparing those who took the drug for eczema or asthma to those who did not. The main goal was to check for any effects on the b…